Curaleaf opened their second cannabis dispensary location in Sarasota, Florida. This marked the opening of their 61st store.
In a recent press release (1), Curaleaf Holdings, Inc. (Curaleaf), unveiled that they had opened their second cannabis dispensary in Sarasota, Florida. It was also marked as the 61st location for the company. The new dispensary can be found at 3704 84th Avenue Circle E, Sarasota, Florida.
In the state of Florida, only medical cannabis is legalized and recreational use is still considered illegal. The new Sarasota location will be open Monday to Saturday from 9am to 8:30pm EST and on Sundays will be accessible from 10am to 7pm EST (1). This business will offer to medical cannabis patients a variety of products. In the press release (1), they mentioned, “an extensive selection of flower and pre-rolls, JAMS and Blue Kudu edibles, as well as the top-selling Select line, including Select Briq, Select Live Rosin, Select Live Rosin X Bites and the innovative vape hardware, Cliq by Select.” Staff members will be able to assist customers with their purchases and will also have the option to purchase items online to be picked up inside the store or via curbside pickup.
"Florida is an important market for us, and Sarasota is a vibrant, populous community that has welcomed Curaleaf with open arms since we launched our first medical dispensary in the area in 2019," Matt Darin, CEO of Curaleaf, commented (1). "We are thrilled to open a second location in this beautiful city to further expand access to the highest quality cannabis on the market, grow our business and build a deeper connection with the people of Sarasota."
At the new dispensary, medical cannabis patients will be able to utilize the company’s rewards program where they will be able to obtain loyalty points from every dollar spent on their order. Those points can then be used on future purchases at any of their 61 cannabis dispensary locations (1).
Reference
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.